CureVac Stock Tumbles After Vaccine Failure. Why More Pain May Be Coming.

Text measurement An worker checked bottles of vaccine diluent at a CureVac provider in France in April. Guillaume Souvant/AFP through

Read more

CureVac Started the Day Worth More Than Novavax. Then Its Vaccine News Hit.

Text measurement CureVac’s vaccine was 47% efficient at stopping Covid-19 signs in a trial of 40,000 volunteers. JEROEN JUMELET/ANP/AFP through

Read more

Novavax Vaccine Is Real Competition for Pfizer and Moderna

Text dimension The Covid vaccine from Novavax is virtually as efficient as these from Pfizer/BioNTech and Moderna—however simpler to distribute.

Read more

U.S. Stocks Tumble on Inflation Concerns

Text dimension The technology-heavy Nasdaq is beneath stress from U.S. inflation considerations. (John Smith/Corbis through Getty Images) A superb old

Read more

The Stock Market Is Slipping. Why Strong Earnings Aren’t Enough.

Earnings rule the market in the long term, and lately reported earnings have been nice. So why are stocks falling?

Read more

Pfizer’s Earnings Are Tuesday. Here’s What to Expect.

Text measurement Pfizer’s success with its Covid-19 vaccine hasn’t given the inventory a giant enhance. Luis Acosta/AFP through Getty Images

Read more

Apple and the Rest of Big Tech Reported Blockbuster Earnings. Why Their Stocks Went Nowhere.

Amazon reported a blowout quarter after Thursday’s shut and now earnings from all the FAANG shares—and Microsoft —are in the

Read more

McKesson Stock May Be the Real Covid Vaccine Winner. Morgan Stanley Explains Why.

Text dimension Boxes containing Moderna’s Covid-19 vaccine are ready for delivery. Paul Sancya/Pool/Getty Images Developing a Covid-19 vaccine in 1

Read more

What could rattle markets in 2021, even as vaccines are rolling out

After a brutal 12 months, it’s laborious to not get enthusiastic about seeing a light-weight on the finish of the

Read more